Antibody–drug conjugates and immunogenic cell death in breast cancer: agent-specific mechanisms, clinical evidence and translational priorities

Linghui Fang, Jialu Song, Xiaohui Wang, Fan Wang, Xiaotao Zhu

Open source

DOI
10.3389/fimmu.2026.1978134
Published
2026-10-22
Container
Frontiers in Immunology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1978134,
  title = {Antibody–drug conjugates and immunogenic cell death in breast cancer: agent-specific mechanisms, clinical evidence and translational priorities},
  author = {Linghui Fang and Jialu Song and Xiaohui Wang and Fan Wang and Xiaotao Zhu},
  year = {2026},
  journal = {Frontiers in Immunology},
  doi = {10.3389/fimmu.2026.1978134},
  url = {https://doi.org/10.3389/fimmu.2026.1978134}
}

RIS

TY  - JOUR
TI  - Antibody–drug conjugates and immunogenic cell death in breast cancer: agent-specific mechanisms, clinical evidence and translational priorities
AU  - Linghui Fang
AU  - Jialu Song
AU  - Xiaohui Wang
AU  - Fan Wang
AU  - Xiaotao Zhu
PY  - 2026
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2026.1978134
UR  - https://doi.org/10.3389/fimmu.2026.1978134
ER  - 

APA

Fang, L., Song, J., Wang, X., Wang, F., & Zhu, X. (2026). Antibody–drug conjugates and immunogenic cell death in breast cancer: agent-specific mechanisms, clinical evidence and translational priorities. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2026.1978134

Source records